HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
26 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
COL11A1
collagen type XI alpha 1 chain
Chromosome 1 · 1p21.1
NCBI Gene: 1301Ensembl: ENSG00000060718.23HGNC: HGNC:2186UniProt: P12107
156PubMed Papers
24Diseases
2Drugs
250Pathogenic Variants
FUNCTIONAL ROLE
Highly Constrained
RESEARCH IMPACT
TrendingVariant-Rich
CLINICAL
FDA Approved TargetOMIM Disease Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
detection of mechanical stimulus involved in sensory perception of soundsensory perception of soundendodermal cell differentiationextracellular matrixStickler syndrome type 2Marshall syndromefibrochondrogenesis 1autosomal dominant nonsyndromic hearing loss
✦AI Summary

COL11A1 encodes the α1 chain of type XI collagen, a minor fibrillar collagen critical for connective tissue organization. Functionally, COL11A1 plays an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils, contributing to extracellular matrix structural integrity and tensile strength 1. The gene is expressed by specific fibroblast subpopulations involved in connective tissue differentiation and matrix deposition 1. Pathogenic COL11A1 variants predominantly exert dominant-negative effects rather than haploinsufficiency, making the mutation location and type critical determinants of disease severity 2. COL11A1 mutations are associated with multiple genetic disorders including Stickler syndrome (dominant and recessive forms), Marshall syndrome, and autosomal dominant deafness-37 34. In Stickler syndrome, COL11A1 mutations specifically cause vitreo-retinal features, sensorineural hearing loss, cleft palate, and premature arthritis 24. Beyond genetic disease, COL11A1 is upregulated in pathological fibrosis contexts, including systemic sclerosis and cancer-associated desmoplasia, where it serves as a biomarker of activated stromal cells and correlates with disease progression and metastatic potential 56. These findings suggest COL11A1 expression distinguishes disease-relevant fibroblast populations in both inherited connective tissue disorders and acquired fibrotic diseases.

Sources cited
1
COL11A1 variants exert dominant-negative effects in Stickler syndrome; variants cause multiple systemic manifestations including retinal detachment, deafness, cleft palate, and arthritis
PMID: 35741851
2
COL11A1+ fibroblasts represent a distinct population involved in connective tissue cell differentiation and matrix deposition
PMID: 29080679
3
COL11A1 mutations cause recessive Stickler syndrome with high myopia, sensorineural hearing loss, cleft palate, and retinal detachment risk
PMID: 35885918
4
COL11A1 is expressed in vitreous and causes vitreo-retinal phenotype in type 2 Stickler syndrome; only COL11A1 among type XI collagen chains is present in vitreous
PMID: 9091360
5
COL11A1 is upregulated in cancer-associated stromal cells and correlates with carcinoma aggressiveness and metastatic progression
PMID: 25761876
6
COL11A1+ fibroblast signatures are increased in systemic sclerosis and correlate with skin fibrosis progression
PMID: 38147960
Disease Associationsⓘ24
Stickler syndrome type 2Open Targets
0.82Strong
Marshall syndromeOpen Targets
0.77Strong
fibrochondrogenesis 1Open Targets
0.75Strong
autosomal dominant nonsyndromic hearing lossOpen Targets
0.69Moderate
fibrochondrogenesisOpen Targets
0.65Moderate
Dupuytren ContractureOpen Targets
0.59Moderate
Stickler syndromeOpen Targets
0.56Moderate
osteoarthritis, hipOpen Targets
0.54Moderate
osteoarthritisOpen Targets
0.52Moderate
lumbar disc degenerationOpen Targets
0.51Moderate
Sensorineural hearing impairmentOpen Targets
0.50Moderate
genetic disorderOpen Targets
0.50Moderate
open-angle glaucomaOpen Targets
0.49Moderate
Abnormality of the skeletal systemOpen Targets
0.48Moderate
hearing lossOpen Targets
0.48Moderate
Skin ulcerOpen Targets
0.46Moderate
TinnitusOpen Targets
0.46Moderate
osteoarthritis, kneeOpen Targets
0.46Moderate
eye diseaseOpen Targets
0.44Moderate
total hip arthroplastyOpen Targets
0.43Moderate
Deafness, autosomal dominant, 37UniProt
Fibrochondrogenesis 1UniProt
Marshall syndromeUniProt
Stickler syndrome 2UniProt
Pathogenic Variants250
NM_001854.4(COL11A1):c.1245+1G>APathogenic
not provided|Intervertebral disc disorder;Stickler syndrome type 2;Hearing loss, autosomal dominant 37;Marshall syndrome;Fibrochondrogenesis 1|COL11A1-related disorder|Stickler syndrome type 2
★★☆☆2026
NM_001854.4(COL11A1):c.3816+2dupPathogenic
Fibrochondrogenesis 1|not provided|Marshall syndrome|Stickler syndrome type 2|Stickler syndrome
★★☆☆2026
NM_001854.4(COL11A1):c.1190dup (p.Pro397_Asn398insTer)Pathogenic
not provided
★★☆☆2025→ Residue 397
NM_001854.4(COL11A1):c.3655-2A>GLikely pathogenic
not provided
★★☆☆2025
NM_001854.4(COL11A1):c.2513G>A (p.Gly838Glu)Pathogenic
not provided|Hearing loss, autosomal dominant 37;Stickler syndrome type 2;Marshall syndrome;Fibrochondrogenesis 1|Stickler syndrome type 2
★★☆☆2025→ Residue 838
NM_001854.4(COL11A1):c.3816+1G>CPathogenic
Marshall syndrome|not provided
★★☆☆2025
NM_001854.4(COL11A1):c.1191del (p.Asn398fs)Pathogenic
not provided|Stickler syndrome type 2|Autosomal dominant COL11A1-related disorders
★★☆☆2025→ Residue 398
NM_001854.4(COL11A1):c.1630-2delPathogenic
not provided|Stickler syndrome|Stickler syndrome type 2|Inborn genetic diseases
★★☆☆2025
NM_001854.4(COL11A1):c.3816+1G>APathogenic
Marshall syndrome|not provided|Inborn genetic diseases|Stickler syndrome type 2|COL11A1-related disorder
★★☆☆2025
NM_001854.4(COL11A1):c.4547G>T (p.Gly1516Val)Pathogenic
not provided|Marshall syndrome|Stickler syndrome type 2;Marshall syndrome;Hearing loss, autosomal dominant 37|Stickler syndrome type 2|COL11A1-related disorder
★★☆☆2025→ Residue 1516
NM_001854.4(COL11A1):c.1003G>T (p.Glu335Ter)Pathogenic
not provided|COL11A1-related disorder
★★☆☆2025→ Residue 335
NM_001854.4(COL11A1):c.2241+5G>TPathogenic
not provided|Intervertebral disc disorder;Stickler syndrome type 2;Fibrochondrogenesis 1;Marshall syndrome;Hearing loss, autosomal dominant 37
★★☆☆2025
NM_001854.4(COL11A1):c.1630-1G>TPathogenic
not provided|Stickler syndrome
★★☆☆2025
NM_001854.4(COL11A1):c.2808+1G>APathogenic
not provided|Stickler syndrome type 2
★★☆☆2025
NM_001854.4(COL11A1):c.1791+1G>TLikely pathogenic
not provided
★★☆☆2025
NM_001854.4(COL11A1):c.990+1G>TLikely pathogenic
not provided
★★☆☆2025
NM_001854.4(COL11A1):c.3740C>G (p.Ser1247Ter)Pathogenic
not provided
★★☆☆2025→ Residue 1247
NM_001854.4(COL11A1):c.3762+2T>CPathogenic
Stickler syndrome type 2
★★☆☆2025
NM_001854.4(COL11A1):c.1900-1G>ALikely pathogenic
not provided
★★☆☆2025
NM_001854.4(COL11A1):c.4032+1G>APathogenic
not provided
★★☆☆2025
View on ClinVar ↗
Drug Targets2
COLLAGENASE CLOSTRIDIUM HISTOLYTICUMApproved
Collagen hydrolytic enzyme
ulcer disease
OCRIPLASMINApproved
Laminin hydrolytic enzyme
Related Genes
COL1A1Protein interaction97%DDR2Protein interaction86%THBS2Protein interaction83%HAPLN1Protein interaction81%COL14A1Protein interaction78%CILPProtein interaction78%
Tissue Expression6 tissues
Brain
100%
Ovary
62%
Bone Marrow
39%
Lung
9%
Liver
3%
Heart
1%
Gene Interaction Network
Click a node to explore
COL11A1COL1A1DDR2THBS2HAPLN1COL14A1CILP
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt P12107
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.35Highly Constrained
pLIⓘ
1.00Intolerant
Observed/Expected LoF0.28 [0.22–0.35]
RankingsWhere COL11A1 stands among ~20K protein-coding genes
  • #2,882of 20,598
    Most Researched156 · top quartile
  • #572of 1,025
    FDA-Approved Drug Targets2
  • #256of 5,498
    Most Pathogenic Variants250 · top 5%
  • #1,534of 17,882
    Most Constrained (LOEUF)0.35 · top 10%
Genes detectedCOL11A1
Sources retrieved26 papers
Response time—
📄 Sources
26▼
1
PMID: 20301479
1.00
2
Dominant Stickler Syndrome.
PMID: 35741851
Genes (Basel) · 2022
0.90
3
Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.
PMID: 37506977
J Allergy Clin Immunol · 2024
0.80
4
SFRP2/DPP4 and FMO1/LSP1 Define Major Fibroblast Populations in Human Skin.
PMID: 29080679
J Invest Dermatol · 2018
0.80
5
Specifications and validation of the ACMG/AMP criteria for clinical interpretation of sequence variants in collagen genes associated with joint hypermobility.
PMID: 37079061
Hum Genet · 2023
0.70